There are currently no sound estimates of the number of children born with a serious congenital disorder
attributable to genetic or environmental causes (World Health Organization) but there is a supposed
number of babies born with birth defects per year: in the world approximately 7.9 million children (6%
of births). There is conducted population-based screening by the individual countries. The specialised
methods are used when it is not possible to diagnose disease in screening. In recent years in the diagnostics
of these disorders the methods of Magnetic Resonance Spectroscopy of the brain(in vivo 1H-MRS) and high
resolution NMR spectroscopy gain in importance. The manuscript focused on developing the method of
marking the metabolic diseases markers of various origins using NMR spectroscopy (including synthesis
of markers). Considering the disorders occurring among children, according to Hoffman, Zschocke, Nyhan,
there are three following groups of inherited metabolic diseases: disorders of intermediary metabolism,
disorders of the biosynthesis and breakdown of complex molecules and neurotransmitter defects and
related disorders. The presented investigation is focused on: a study of selected compounds that cause
disorders of intermediary metabolism, a study of compounds that cause disorders of the biosynthesis
and breakdown of complex molecules and a study of compounds that cause neurotransmitter defects and
related disorders. In the subsequent chapter of manu script there are presented the results of investigation
concerning the metabolism of xenobiotics that could potentially be used in therapy of inherited metabolic
diseases, basing on stilbene derivatives.
In the last chapter there are presented the results of experiments with creatinine- the metabolite
produced in muscles